Juniper Pharma (JNP) Tops Q1 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. CRGY
5. LULU
6. PEP
7. DVN
8. ANGO
9. BCO
10. NATL

Go back to Juniper Pharma (JNP) Tops Q1 EPS by 4c

Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results

May 10, 2018 7:00 AM EDT

BOSTON, May 10, 2018 /PRNewswire/ -- Juniper Pharmaceuticals (Nasdaq: JNP), a diversified healthcare company with core businesses of its CRINONE® (progesterone gel) franchise and fee-for-service pharmaceutical development and manufacturing business, JPS, today announced financial results for the three-month period ended March 31, 2018. Cash and equivalents were $20.7 million at March 31, 2018 compared to $21.4 million at December 31, 2017.

"We made tremendous progress thus far this year having achieved two important strategic priorities for 2018 aimed at building shareholder value, while also driving strong growth momentum in our core businesses," said Alicia Secor, Chief Executive Officer. "At... More